Literature DB >> 31901041

[Analysis of Alport syndrome induced by type IV collagen alpha 5 gene mutation in two families].

Qing Ye1, Yingying Zhang2, Jingjing Wang2, Jianhua Mao2.   

Abstract

OBJECTIVE: To investigate genetic characteristics of Alport syndrome.
METHODS: High-throughput sequencing-based whole exome sequencing was performed in two patients with recurrent unexplained abnormal urinalysis. The pathogenicity of the genetic variations, type of Mendelian genetics, and clinical phenotypes were analysed, and the disease-cause mutations were confirmed in the family members using Sanger sequencing.
RESULTS: Two heterozygous splice site mutations of COL4A5 gene c.2147-2A > T (IVS27) and c.646-2A > G (IVS11) (NM_033380) were found in patients of the two families, which showed a co-segregation association with the affected members of the families.
CONCLUSIONS: Alport syndrome is mainly inherited from direct female patients, and prenatal genetic screening based on amniotic fluid testing can effectively prevent birth defects in patients with a family history of this characteristic phenotype.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31901041      PMCID: PMC8800710          DOI: 10.3785/j.issn.1008-9292.2019.08.06

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  21 in total

Review 1.  Alport's syndrome, Goodpasture's syndrome, and type IV collagen.

Authors:  Billy G Hudson; Karl Tryggvason; Munirathinam Sundaramoorthy; Eric G Neilson
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

2.  HEREDITARY FAMILIAL CONGENITAL HAEMORRHAGIC NEPHRITIS.

Authors:  A C Alport
Journal:  Br Med J       Date:  1927-03-19

3.  Efficacy and safety of losartan in children with Alport syndrome--results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial.

Authors:  Nicholas J A Webb; Chun Lam; Shahnaz Shahinfar; Juergen Strehlau; Thomas G Wells; Gilbert W Gleim; Céline Le Bailly De Tilleghem
Journal:  Nephrol Dial Transplant       Date:  2011-02-01       Impact factor: 5.992

Review 4.  Ocular features in Alport syndrome: pathogenesis and clinical significance.

Authors:  Judy Savige; Shivanand Sheth; Anita Leys; Anjali Nicholson; Heather G Mack; Deb Colville
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-03       Impact factor: 8.237

5.  The Alport syndrome COL4A5 variant database.

Authors:  David K Crockett; Genevieve Pont-Kingdon; Frederick Gedge; Kelli Sumner; Ryan Seamons; Elaine Lyon
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

6.  Alport's syndrome. A report of 58 cases and a review of the literature.

Authors:  M Gubler; M Levy; M Broyer; C Naizot; G Gonzales; D Perrin; R Habib
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

7.  Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome.

Authors:  T Mochizuki; H H Lemmink; M Mariyama; C Antignac; M C Gubler; Y Pirson; C Verellen-Dumoulin; B Chan; C H Schröder; H J Smeets
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

8.  Genetic heterogeneity among kindreds with Alport syndrome.

Authors:  S J Hasstedt; C L Atkin; A C San Juan
Journal:  Am J Hum Genet       Date:  1986-06       Impact factor: 11.025

Review 9.  Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis.

Authors:  Mark Haas
Journal:  Arch Pathol Lab Med       Date:  2009-02       Impact factor: 5.534

10.  Phenotypic heterogeneity in females with X-linked Alport syndrome.

Authors:  Samuel C Allred; Karen E Weck; Adil Gasim; Amy K Mottl
Journal:  Clin Nephrol       Date:  2015-11       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.